Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Sterile Injection Manufacturing: SOP for Packaging of Temperature-Sensitive Injectable Products – V 2.0

Posted on By

Sterile Injection Manufacturing: SOP for Packaging of Temperature-Sensitive Injectable Products – V 2.0

Standard Operating Procedure for Packaging of Temperature-Sensitive Injectable Products


Department Sterile Injection Manufacturing
SOP No. SOP/SIM/197/2025
Supersedes SOP/SIM/197/2022
Page No. Page 1 of 14
Issue Date 24/06/2025
Effective Date 26/06/2025
Review Date 24/06/2026

1. Purpose

To define the procedure for the proper packaging of temperature-sensitive injectable products to ensure the integrity, efficacy, and compliance of the finished products with regulatory standards during storage, handling, and transportation.

2. Scope

This SOP applies to all temperature-sensitive injectable products manufactured in the Sterile Injection Manufacturing department, including

vials, ampoules, and prefilled syringes that require controlled temperature conditions during secondary and tertiary packaging.

3. Responsibilities

  • Packaging Operators: Execute the packaging activity as per the SOP.
  • QA Personnel: Verify temperature-sensitive packaging compliance and approve batch for dispatch.
  • Warehouse Staff: Provide validated packaging materials and manage cold storage logistics.
  • Engineering Team: Ensure temperature monitoring systems in packaging and storage areas are functional.

4. Accountability

The Head of Production and Head of Quality Assurance are accountable for ensuring adherence to this SOP and for maintaining packaging conditions suitable for temperature-sensitive injectable products.

See also  Sterile Injectable Manufacturing: SOP for Sanitization of Airlocks in Sterile Manufacturing Facilities - V 2.0

5. Procedure

5.1 Preparation and Verification of Packaging Materials

  1. Obtain the list of temperature-sensitive products to be packed from the production planner or batch processing record (BPR).
  2. Ensure all secondary and tertiary packaging materials (insulated shippers, gel packs, thermal indicators) are available and validated for the specified temperature range (e.g., 2–8°C).
  3. Check the calibration status of temperature monitoring devices (e.g., data loggers, IR thermometers).

5.2 Conditioning and Pre-Assembly

  1. Precondition insulated shippers and gel packs as per vendor instructions or validation protocol.
  2. Verify that conditioned materials are maintained within the required range before use.
  3. Set up the packaging area within a temperature-controlled zone (if applicable) or monitor ambient temperature during the operation.

5.3 Packaging Process

  1. Transfer labeled, packed primary units from cold room or refrigerated area to packaging area using validated cold boxes.
  2. Insert temperature indicators or data loggers in each shipping unit as per the SOP.
  3. Layer the secondary and tertiary components:
    • Line the insulated shipper with gel packs as per validated layout.
    • Place injectable units in sterile polybags or trays.
    • Insert product leaflet and label correctly.
    • Seal the shipper and apply external shipping label with temperature sensitivity warning.
See also  Sterile Injectable Manufacturing: SOP for Cleaning and Disinfecting Cleanroom Pass-Through Chambers - V 2.0

5.4 Labeling and Documentation

  1. Ensure that each package label includes:
    • Product name and strength
    • Batch number
    • Storage temperature range (e.g., “Store between 2°C and 8°C”)
    • Shipping and handling instructions
  2. Record packaging details in the Temperature-Sensitive Packaging Log (Annexure-1).

5.5 Final QA Review and Release

  1. QA shall:
    • Verify packaging against approved checklist
    • Confirm data logger configuration and functionality
    • Approve the release of final packed units

5.6 Transportation Coordination

  1. Coordinate with the dispatch team and logistics provider to ensure cold chain continuity.
  2. Review transportation SOP and instruct the carrier on necessary precautions.

5.7 Deviations and Corrective Actions

  1. Record any observed temperature excursions in the deviation register.
  2. Initiate CAPA and document findings in the deviation form (Annexure-2).

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • BPR: Batch Processing Record
  • CAPA: Corrective and Preventive Action
See also  Sterile Injectable Manufacturing: SOP for Conducting Operational Qualification (OQ) for Machines - V 2.0

7. Documents

  1. Temperature-Sensitive Packaging Log – Annexure-1
  2. Deviation Form – Annexure-2

8. References

  • WHO Technical Report Series 961 – Annex 9: Model Guidance for the Storage and Transport of Time- and Temperature–Sensitive Pharmaceutical Products
  • ICH Q10 – Pharmaceutical Quality System

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation Packaging Executive QA Executive Head QA
Department Sterile Injection Manufacturing Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Temperature-Sensitive Packaging Log

Date Batch No. Product Pack Size Shipper ID Logger ID Packaged By
24/06/2025 BTP-0256 Ceftriaxone 1g Injection 10 vials SHIP-08 LOG-9234 Ravi Shankar

Annexure-2: Deviation Form

Deviation ID Date Description Root Cause CAPA Closed By
DEV-074 24/06/2025 Temperature spike to 9°C during loading Delay in cold van arrival Vendor re-trained, response time SOP updated Sunita Reddy

Revision History:

Revision Date Revision No. Revision Details Reason Approved By
01/05/2022 1.0 Initial release New SOP QA Head
24/06/2025 2.0 Updated procedure and annexures Periodic Review QA Head
Injectables V 2.0 Tags:Aseptic processing SOP, Aseptic technique in sterile manufacturing, Cleanroom SOP for injectables, SOP for ampoule sealing, SOP for autoclave sterilization, SOP for container closure integrity testing, SOP for environmental monitoring in aseptic area, SOP for gowning in cleanroom, SOP for in-process checks in sterile manufacturing, SOP for injectable formulation, SOP for lyophilizer operation, SOP for sterile filtration, SOP for sterilization validation, SOP for vial filling, SOP for visual inspection of injectables, Sterile area cleaning SOP, Sterile filling line SOP, Sterile injectable quality control SOP, Sterile injection SOP, Sterile manufacturing procedure

Post navigation

Previous Post: Trending SOP Violations: From Data to Action
Next Post: Biosimilars: SOP for Resin Performance Qualification – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version